Helicobacter pylori infection in skin diseases: A critical appraisal

American Journal of Clinical Dermatology

Volumn 3, Issue 4, 2002, Pages 273-282

  Wedi, Bettina ^a   Kapp, Alexander ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; COMPLEMENT COMPONENT C1S INHIBITOR; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ANAPHYLACTOID PURPURA; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BACTERIAL SKIN DISEASE; BEHCET DISEASE; CHRONIC URTICARIA; CLINICAL TRIAL; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; LICHEN PLANUS; MEDLINE; PEPTIC ULCER; PRIORITY JOURNAL; PRURIGO; PRURITUS; PSORIASIS; REVIEW; ROSACEA; SJOEGREN SYNDROME; STOMACH CANCER; SYSTEMIC SCLEROSIS; UREA BREATH TEST;

EID: 0036278128     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203040-00005     Document Type: Review

References (112)

1. Rate of Helicobacter pylori acquisition among Finnish adults: A fifteen year follow-up
2. Determinants of ethnic or geographical differences in infectivity and transmissibility of Helicobacter pylori
3. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin
4. Lymphoma of the gastrointestinal tract
5. Helicobacter pylori infection and gastric cancer: Systematic review of the epidemiologic studies
6. Mucosa-associated lymphoid tissue lymphoma
7. Helicobacter pylori and gastric cancer
8. Helicobacter pylori
9. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease?
10. Living dangerously: How Helicobacter pylori survives in the human stomach
11. Possible mechanisms and mediators of gastritis associated with Helicobacter pylori infection
12. Platelet activation in mice and human Helicobacter pylori infection
13. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication
14. Blood leukocyte differential in Helicobacter pylori infection
15. Role of antigastric autoantibodies in chronic Helicobacter pylori infection
16. Extradigestive manifestations of helicobacter pylori gastric infection
17. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis
18. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine
19. Exposure to food-borne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: Epidemiological study
20. Non-gastrointestinal tract associations of Helicobacter pylori infection
21. Extradigestive manifestations of Helicobacter pylori infection: Fact and fiction
22. Helicobacter pylori serology in patients with coeliac disease and dermatitis herpetiformis
23. Helicobacter pylori and Behçet's disease
24. Helicobacter pylori in rosacea: Lack of an association
25. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: Association with esophageal involvement
26. Helicobacter pylori in out-patients of a general practitioner: Prevalence and determinants of current infection
27. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany
28. Prevalence of Helicobacter pylori associated gastritis in chronic urticaria
29. Helicobacter pylori infection and chronic urticaria
30. Familial clustering of Helicobacter pylori infection: Population based study
31. Chronic urticaria and Helicobacter pylori
32. Helicobacter pylori in patients with rosacea
33. Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England
34. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland
35. Gastritis classified in accordance with the Sidney system in patients with primary Sjögren's syndrome
36. Seroprevalance of Helicobacter pylori infection in an asymptomatic Turkish population
37. Helicobacter pylori eradication treatment reduces the severity of rosacea
38. The risk of Helicobacter pylori infection among U.S. military personnel deployed outside the United States
39. Effect of treatment of Helicobacter pylori infection on rosacea
40. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea
41. Helicobacter pylori antibodies in patients with psoriasis
42. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan
43. The impact of chronic urticaria on the quality of life
44. The extent and nature of disability in different urticarial conditions
45. Urticaria and angio-oedema: A review of 554 patients
46. Physical urticaria: Classification and diagnostic guidelines: An EAACI position paper
47. Urticaria and angioedema: A clinical spectrum
48. Diagnosis of chronic urticaria: A critical analysis of the results, based on catamnestic investigations
49. Acquired angioedema associated with sinusitis
50. Most chronic urticaria is food-dependent, and not idiopathic
51. In vitro diagnosis of pseudoallergic reactions: New aspects
52. Pseudoallergen-free diet in the treatment of chronic urticaria: A prospective study
53. Acute and chronic urticaria and angioedema
54. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: A study of 90 patients
55. Resolution of chronic urticaria in patients with thyroid autoimmunity
56. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
57. The anti-IgE/anti-FcεRIα autoantibody network in allergic and autoimmune diseases
58. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria
59. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria
60. Anti-FcepsilonRIalpha autoantibodbodies in autoimmune-mediated disorders: Identification of a structure-function relationship
61. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria
62. Chronic urticaria serum induces histamine release, leukotriene production and basophil CD63 surface expression: Inhibitory effects of anti-inflammatory drugs
63. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria
64. Human anti-FcεRIα autoantibodies isolated from healthy donors cross-react with tetanus toxoid
65. Has eradication therapy an effect in Helicobacter-positive patients with chronic urticaria?
66. Chronic idiopathic urticaria: Natural course and association with Helicobacter pylori infection
67. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany
68. An increase in Helicobacter pylori strains resistant to metronidazole: A five-year study
69. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients
70. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases
71. Helicobacter pylori: A possible etiologic factor of chronic urticaria
72. Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria
73. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria
74. Helicobacter pylori as a possible bacterial focus of chronic urticaria
75. Helicobacter pylori and idiopathic chronic urticaria
76. Helicobacter pylori eradication in patients with chronic urticaria
77. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy
78. Helicobacter pylori and prurigo nodularis
79. Association of Helicobacter pylori infection with psoriasis and lichen planus: Prevalence and effect of eradication therapy
80. Relationship between Helicobacter pylori and rosacea: It may be a myth
81. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection
82. Angioedema due to acquired Cl-esterase inhibitor deficiency in a patient with Helicobacter pylori infection
83. Atopic dermatitis successfully treated by eradication of Helicobacter pylori
84. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection
85. Schonlein-Henoch purpura associated with gastric Helicobacter pylori infection
86. Schonlein-Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: A case report
87. Schonlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection
88. Sweet's syndrome associated with Helicobacter pylori infection
89. Helicobacter pylori in patients with systemic sclerosis: Detection with the 13C-urea breath test and eradication
90. Sjögren's syndrome and Helicobacter pylori infection
91. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
92. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
93. Cag, a pathogenicity island of Helicobacter pylori encodes type-I-specific and disease-associated virulence factors
94. The design of vaccines against Helicobacter pylori and their development
95. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori
96. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
97. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication
98. Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment
99. Relationship between Helicobacter pylori colonization and acute inflammation of the duodenal mucosa
100. Mechanisms involved in Helicobacter pylori-induced inflammation
101. Modulatory action of Helicobacter pylori on histamine release from mast cells and basophils in vitro
102. Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori
103. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis
104. The role of superantigens in human diseases: Therapeutic implications for the treatment of skin diseases
105. Helicobacter pylori infection and vascular disease
106. Helicobacter pylori-induced microvascular protein leakage in rats: Role of neutrophils, mast cells, and platelets
107. Helicobacter pylori infection and the risk of myocardial infarction: Role of fibrinogen and its genetic control
108. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria
109. Correlation of infect-associated chronic urticaria with positive autologous serum skin test
110. A flagellar sheat protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGFS cells
111. Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane laminin
112. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases